论文部分内容阅读
目的:了解我院2006年度抗肿瘤药物的使用情况。方法:采用金额和用药频度排序法对药物的使用情况进行统计分析。结果:抗肿瘤药物用药金额列前3位依次为紫杉醇(13.13%)、参芪扶正注射液(11.40%)、吉西他宾(9.47%);用药频度前3位依次为他莫西芬(26.28%)、格拉司琼(7.86%)、参芪扶正注射液(7.14%)。结论:我院抗肿瘤药使用状况比较合理;抗肿瘤植物药和中药类已经成为肿瘤用药的主要趋势,还应加快国产化疗药物及化疗辅助药物的研制,以降低费用,减轻患者负担。
Objective: To understand the use of anticancer drugs in our hospital in 2006. Methods: Using the amount and medication frequency sorting method for statistical analysis of the use of drugs. Results: The first three doses of antineoplastic drugs were paclitaxel (13.13%), Shenqi Fuzheng injection (11.40%) and gemcitabine (9.47%). The top three drugs were tamoxifen (26.28%), granisetron (7.86%) and Shenqi Fuzheng injection (7.14%). Conclusion: The use of anti-tumor drugs in our hospital is quite reasonable. Anti-tumor botanicals and traditional Chinese medicines have become the main trend of tumor drugs. The development of home-made chemotherapeutic drugs and chemotherapy auxiliary drugs should also be accelerated in order to reduce costs and reduce the burden on patients.